Further pause to NMS quarterly data reporting

Recognising the current challenges being experienced by pharmacies and the contribution of the pharmacy workforce to the COVID-19 vaccination programme, NHS England and NHS Improvement and PSNC have agreed that there should be no requirement to report New Medicine Service (NMS) data for Quarters 3 and 4 of 2021/22.

The requirement to submit data will be reinstated from Quarter 1 of 2022/23 (April – June 2022), with contractors submitting their quarterly data in early July 2022.